How Long Should We Follow Patients With Soft Tissue Sarcomas?
Chigusa Sawamura(Tokyo Medical and Dental University), Keisuke Ae(The Cancer Institute Hospital), Atsushi Okawa(Research Institute of Economy, Trade and Industry), Seiichi Matsumoto(Fukuda Denshi (Japan)), Takashi Shimoji(Japanese Foundation For Cancer Research)
Cited by 40
Related Papers
Clear Cell Sarcoma of Soft Tissue
|The American Journal of Surgical Pathology|2008|283
Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A
|Proceedings of the National Academy of Sciences|2018|264
Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 Cases
|International Journal of Radiation Oncology*Biology*Physics|2016|182
Vitamin E decreases bone mass by stimulating osteoclast fusion
|Nature Medicine|2012|174
Regulation of iron homeostasis by the p53-ISCU pathway
|Scientific Reports|2015|108